Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42 SEK | -74.28% |
|
-5.78% | -38.73% |
31/05 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
31/05 | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT |
---|
Technical Rankings Surperformance
- Stock Market
- Equities
- HNSA Stock
- Stock
- Charts Hansa Biopharma AB
- Comparison Chart